The total number of tumor samples from individual cancer types varied from 36 (CHOL) to 1,084 (BRCA), and those with too few tumor samples might not represent the complete picture of FGFR2 mutation status (Supplementary Table 2). This evidence concerns the gene FGFR2 and neoplasm.